Janus kinase inhibitors in autoimmune bullous diseases

Autoimmune bullous disease (AIBD) is a severe skin disorder caused by autoantibodies that target intercellular or cell-matrix adhesion proteins. Currently, the preferred treatment for AIBD involves the use of glucocorticoids or traditional immunosuppressants. Additionally, the utilization of biologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Dawei, Zhang, Yuexin, Kong, Luyang, Lu, Jiajing, Shi, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363722/
https://www.ncbi.nlm.nih.gov/pubmed/37492565
http://dx.doi.org/10.3389/fimmu.2023.1220887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363722/
https://www.ncbi.nlm.nih.gov/pubmed/37492565
http://dx.doi.org/10.3389/fimmu.2023.1220887

Ejemplares similares